Which statement describes a pharmacodynamic difference between albuterol and salmeterol?
Albuterol is considered “long-acting” and salmeterol is considered “short-acting.”
Albuterol is considered “short-acting” and salmeterol is considered “long-acting.”
Salmeterol’s effects last for 3 to 4 hours, and albuterol has an extended duration of action up to 12 hours.
Because of the onset of action, albuterol should not be used during an acute attack of asthma, but instead, salmeterol should be used.
The Correct Answer is B
Choice A reason: Albuterol is a short-acting beta-2 agonist (SABA), with effects lasting 4-6 hours, while salmeterol is a long-acting beta-2 agonist (LABA), lasting up to 12 hours. This statement reverses their durations, making it incorrect, as albuterol is used for acute relief, not maintenance.
Choice B reason: Albuterol, a SABA, acts within minutes and lasts 4-6 hours, ideal for acute asthma relief. Salmeterol, a LABA, has a slower onset (20-30 minutes) and lasts 12 hours, used for maintenance. This pharmacodynamic difference in duration makes this the correct statement.
Choice C reason: Salmeterol’s effects last up to 12 hours, not 3-4 hours, and albuterol’s duration is 4-6 hours, not 12 hours. This statement inaccurately describes their pharmacodynamic profiles, as salmeterol is long-acting and albuterol is short-acting, making it incorrect.
Choice D reason: Albuterol’s rapid onset (within minutes) makes it ideal for acute asthma attacks, while salmeterol’s slow onset (20-30 minutes) makes it unsuitable for acute relief. This statement is incorrect, as albuterol, not salmeterol, is the first-line rescue medication for asthma exacerbations.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A reason: Protamine sulfate is the antidote for heparin overdose, neutralizing heparin’s anticoagulant effect by binding to it, forming an inactive complex. This reverses excessive anticoagulation, reducing bleeding risk in patients with prolonged aPTT (e.g., 90 seconds), making it the appropriate treatment for heparin-induced bleeding.
Choice B reason: Vitamin E has no role in reversing heparin-induced bleeding. It is an antioxidant with potential antiplatelet effects, which could worsen bleeding. Heparin’s action, enhancing antithrombin to inhibit thrombin and factor Xa, is specifically countered by protamine sulfate, not vitamin E.
Choice C reason: Vitamin K reverses warfarin, not heparin, by restoring vitamin K-dependent clotting factors. Heparin acts via antithrombin, independent of vitamin K, and its overdose causes bleeding correctable by protamine sulfate. Vitamin K is ineffective for heparin-related bleeding, making this incorrect.
Choice D reason: Potassium chloride treats hypokalemia, not heparin-induced bleeding. Heparin’s anticoagulant effect, prolonging aPTT, is unrelated to potassium levels. Administering potassium chloride would not address excessive anticoagulation or bleeding, making it irrelevant for managing heparin overdose complications.
Correct Answer is D
Explanation
Choice A reason: The 1 to 5 mcg/mL range is too low for theophylline’s therapeutic effect. Theophylline, a methylxanthine, requires 10-20 mcg/mL to achieve bronchodilation by inhibiting phosphodiesterase and increasing cyclic AMP. Levels below this range are ineffective for asthma or COPD management, risking suboptimal control.
Choice B reason: The 30 to 40 mcg/mL range is toxic for theophylline. Levels above 20 mcg/mL can cause serious side effects like seizures, arrhythmias, or nausea due to its narrow therapeutic index. Therapeutic monitoring ensures levels stay within 10-20 mcg/mL for safe and effective bronchodilation.
Choice C reason: The 50 to 60 mcg/mL range is far above theophylline’s therapeutic range, leading to severe toxicity, including life-threatening arrhythmias or convulsions. Theophylline’s efficacy for airway relaxation occurs at 10-20 mcg/mL, and such high levels are dangerous, requiring immediate intervention to reduce toxicity risks.
Choice D reason: The 10 to 20 mcg/mL range is the targeted therapeutic range for theophylline in adults. Within this range, theophylline inhibits phosphodiesterase, increasing cyclic AMP, promoting bronchodilation, and relieving asthma or COPD symptoms. Monitoring ensures efficacy while minimizing toxicity risks like tachycardia or seizures.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.